Year In Review
2022 was a year of remarkable success for Cognivia.
Thank you to our team, partners and clients for your continued support! Here are highlights from this year – from exciting company updates to thought leadership articles.
News
News
News
Cognivia Named Finalist for the Award of ‘Scale-up de l’Année – Scale-up of the Year 2022’
We are proud to be a finalist for the award of ‘Scale-up de l’Année – Scale-up of the…
News
Cognivia CEO Dominique Demolle, PhD, Named Among 2022’s Most Inspiring People by PharmaVoice
We are pleased to share that our very own Dominique Demolle, CEO, has been recognized as one of…
News
New Cognivia article in Drug Development & Discovery on “Cracking Down on the Rising Costs of Drug Development”
Drug development has changed significantly throughout the past 2 decades – including great leaps forward in areas from…
News
New Cognivia interview in Medical News Today on COVID-19 vaccines and ‘nocebo’ effect
New research suggests that a high percentage of reported side effects from COVID-19 vaccines may be due to what’s…
News
New Cognivia article in Applied Clinical Trials on “Using Machine Learning to Predict Placebo Response and Increase Clinical Trial Success”
The overall risk of clinical trial failure is still too high – meaning more repeat trials, lost timelines…